InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

CG Oncology, Inc.

CGON Clue Score59
United States Fiscal year ends December CIK 0001991792 Results filed 6 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Leonard E Post
15 Oct 2026
Director
Sold after exercise
500
$62.48
$31.24K
Leonard E Post
15 Oct 2026
Director
Sold after exercise
500
$61.65
$30.83K
Leonard E Post
15 Sep 2026
Director
Sold after exercise
1,000
$72.98
$72.98K
Leonard E Post
14 Aug 2026
Director
Sold after exercise
1,000
$74.54
$74.54K
Leonard E Post
15 Jul 2026
Director
Sold after exercise
1,000
$71.17
$71.17K
James Mulay
10 Jul 2026
Director
Sold after exercise
24,165
$75.16
$1.82M
Brian Guan-Chyun Liu
25 Jun 2026
Director
Buy indirect
371,085
$66.87
$24.81M
Leonard E Post
24 Jun 2026
Director
Sold after exercise
5,000
$70.00
$350.00K
Leonard E Post
22 Jun 2026
Director
Sold after exercise
5,000
$65.00
$325.00K
James Mulay
15 Jun 2026
Director
Sold after exercise
1,310
$60.12
$78.76K
James Mulay
15 Jun 2026
Director
Sold after exercise
654
$60.12
$39.32K
Leonard E Post
4 Jun 2026
Director
Sold after exercise
1,000
$54.50
$54.50K
James Mulay
17 Apr 2026
Director
Sold after exercise
15,600
$73.01
$1.14M
James Mulay
16 Mar 2026
Director
Sold after exercise
1,310
$63.50
$83.19K
James Mulay
16 Mar 2026
Director
Sold after exercise
654
$63.50
$41.53K
Arthur Kuan
12 Mar 2026
Chief Executive Officer
Exercised, kept
64,612
$1.72
$111.13K
Arthur Kuan
4 Mar 2026
Chief Executive Officer
Exercised, kept
102,871
$1.72
$176.94K
James Mulay
9 Jan 2026
Director
Sold after exercise
10,491
$52.99
$555.92K
James Mulay
9 Jan 2026
Director
Sold after exercise
654
$44.16
$28.88K
Leonard E Post
17 Nov 2025
Director
Sold after exercise
1,000
$41.43
$41.43K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 17
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 243,039
History held since 26 Jan 2024